Analytical Testing Services for Drug Packaging & Delivery
Scientists performing analytical testing for pharmaceutical packaging and drug delivery systems

Analytical Testing

Expert testing and analysis to navigate complex regulatory requirements and ensure drug product quality

Request More Information

Why choose our analytical testing

Achievement

As a key element of the West Vantage™ offering, West’s analytical services team brings more than 20 years of experience in extractables and leachables, microscopy and particle analysis, container closure integrity, compendial and performance testing for packaging and delivery systems.

image

Our deep understanding of materials, delivery systems, and their compatibility with drug products enables us to design robust studies and guide customers through the evolving regulatory landscape. Whether you’re developing a new biologic, advancing a combination product, or managing your product lifecycle, our GMP-compliant laboratories provide the comprehensive testing and technical expertise you need for regulatory success.

regulatory

West analytical laboratories are GMP- and FDA-compliant, DEA-licensed, and certified to ISO 9001:2015 and ISO 15378: 2017. Our facilities hold two MHRA (Medicines and Healthcare products Regulatory Agency) certificates, ensuring our testing meets the highest international standards.

Want to Learn More about our Analytical Testing Services?

Explore more West VantageTM Services

Frequently Asked Questions (FAQs)

West’s extractables and leachables (E&L) testing suite covers everything from utilization of aggressive solvents and extraction techniques to determine the potential of all compounds to migrate from the packaging components, determination of target leachables, development of leachables methods specific to customer’s product and packaging, creation of leachables stability study to test for leachables based on the customer’s specific test methods over the shelf-life of the product, and generation of reports at each interim time point and final summary. Testing is performed in alignment with USP <1663> and USP <1664> using appropriate chromatographic, spectrometric, and complementary analytical techniques to support material qualification and regulatory submissions.

West provides container closure integrity (CCI) testing using USP <1207>-aligned probabilistic and deterministic methods, including helium leak testing, laser-based gas headspace analysis, vacuum decay, and dye ingress. These methodologies support quantitative package integrity assessment across a broad temperature range and are used for component selection/fit and capping qualification during development phase, as well as when changes are made to package component design, materials, assembly, and/or processing, and during stability studies as well as shipping and distribution testing.

West offers performance testing for drug packaging and combination products through design verification and release testing aligned with ISO 11040 and ISO 11608, in addition to USP <382> functional suitability testing. These services evaluate critical performance attributes such as dimensional conformity, mechanical functionality, and system performance to support development and commercial release.

West offers particle analysis and microscopy testing including DICM-based glass delamination assessment, FlowCam® 8100 particle imaging and characterization, and SEM/EDX for morphology and elemental analysis. These capabilities support investigations and compendial testing aligned with USP <787>, USP <788>, and USP <789> for visible and subvisible particulate characterization.

West Services and Solutions LLC, a business unit of West Pharmaceutical Services, Inc., provides its West Vantage™ drug delivery device development andmanufacturing solutions to pharmaceutical and biotech customers.